Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_assertion description "[Treatment of ovarian cancer HEY cells with 500 nM 5alpha-dihydrotestosterone (DHT), but not estradiol-17beta or progesterone, for 60 h down-regulated the expression of mRNA for TGF-beta receptors I and II (TbetaR-I and TbetaR-II), betaglycan, and endoglin but had no effect on TGF-beta1 mRNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_assertion evidence source_evidence_literature NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_assertion SIO_000772 10706107 NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_assertion wasDerivedFrom befree-20150227 NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_assertion wasGeneratedBy ECO_0000203 NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP734355.RACAgpuzC-yHMKYdz1n9slxsLzkLRdkP31t2QHDFFG_zI130_provenance.